DoD Autism, Discovery Award
ID: 353820Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353820
Timeline
    Description

    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is offering the FY24 Autism Discovery Award, a federal grant aimed at funding innovative research projects related to Autism Spectrum Disorders (ASD). This grant supports high-risk, potentially high-reward studies that seek to improve outcomes for individuals with ASD and their families, emphasizing the importance of collaboration with community members and the generation of robust preliminary data for future research. With an estimated total program funding of $640,000 and the expectation of awarding two grants, applications are due by August 15, 2024, and must follow a two-step submission process via the eBRAP and Grants.gov portals. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524ARPDA_GG.pdf
    The Department of Defense's FY24 Autism Discovery Award program, managed by the U.S. Army Medical Research Acquisition Activity, offers funding for innovative research projects related to Autism Spectrum Disorders (ASD). The total budget for FY24 is $15 million, available for high-risk, potentially high-reward studies that aim to improve outcomes for individuals with ASD and their families. Applications are invited from eligible organizations, including intramural and extramural entities, with a submission deadline for full applications set for August 15, 2024. The funding supports non-incremental research and emphasizes collaboration with community members for enhanced impact. Key application requirements include a two-step process involving a pre-application and full application via the eBRAP and Grants.gov portals. Proposed projects must not seek to conduct clinical trials but may include other forms of clinical research. Each application will undergo a peer review process based on criteria such as innovation, feasibility, and potential impact on the ASD community. The anticipated budget for each project should not exceed $200,000 for up to two years. Successful grants will be announced no later than September 30, 2025, contingent upon the availability of federal funds. This program aligns with the DOD's goals to advance medical research and provide significant benefits to military members, veterans, and the general public.
    Similar Opportunities
    DoD Arthritis, Focused Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the DoD Arthritis Focused Research Award (Funding Opportunity Number: HT942524ATRPFRA) to support innovative research aimed at improving patient care for individuals affected by arthritis. This grant encourages applications that explore high-risk, high-reward research addressing various types of arthritis, including osteoarthritis and rheumatoid arthritis, with a particular focus on the implications for military personnel and their families. The total funding available for FY24 is approximately $2.5 million, with individual project budgets capped at $750,000 for Research Level 2 and $500,000 for Research Level 1. Interested applicants must submit a pre-application by October 16, 2024, and a full application by October 30, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research on Autism Spectrum Disorders (ASD) through the R21 grant mechanism, aimed at elucidating the etiology, epidemiology, diagnosis, and service delivery methods related to ASD. This initiative encourages exploratory and developmental research without the need for preliminary data, allowing for innovative studies on genetic and environmental factors, early diagnosis, brain mechanisms, and cognitive skills. The total budget for projects is capped at $275,000 over two years, and applications are accepted from a wide range of eligible entities, including educational institutions and nonprofit organizations. Interested applicants must submit their proposals electronically via Grants.gov by November 16, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for any inquiries regarding the funding announcement.
    DoD Arthritis Research, Clinical Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Arthritis Research Clinical Research Award (ATRP CRA) to support clinical research aimed at improving the understanding and management of various forms of arthritis, particularly in military personnel and their families. This grant program encourages innovative research proposals that address disease-specific factors and interventions, with a focus on enhancing patient outcomes and informing clinical care or policy. With an estimated total funding of $6 million, the program anticipates awarding approximately three grants, including one for a clinical trial, with applications due by October 30, 2024, and a pre-application deadline of October 16, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Combat Readiness - Medical Translational Research Award (CRRP TRA) to support high-impact translational research aimed at enhancing medical readiness for military personnel. This funding opportunity seeks proposals that address critical areas such as battlefield diagnostics, treatments for life-threatening injuries, and operational health threats, with an emphasis on projects that leverage existing resources and demonstrate clear relevance to military health. The total estimated funding for this initiative is approximately $3.3 million, with the expectation of awarding around three grants, and key deadlines include pre-applications due by September 4, 2024, and full proposals by December 5, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD Glioblastoma, Resource Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Glioblastoma Resource Development Award, aimed at enhancing research capabilities for glioblastoma, a malignant brain tumor. This grant supports the development of preclinical model systems that improve the understanding and treatment of glioblastoma, with a focus on innovative approaches such as animal models, organoids, and patient-derived xenografts. With a total funding pool of $4 million, the program anticipates awarding up to five grants, each capped at $500,000 over three years. Interested applicants must submit a pre-application by November 6, 2024, followed by a full application due by November 20, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD Glioblastoma, Hypothesis Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Glioblastoma Hypothesis Development Award, aimed at funding innovative research to improve glioblastoma patient outcomes. This grant supports exploratory projects that address significant issues in glioblastoma research, particularly in areas such as drug delivery and biomarker identification, without requiring preliminary data. The total estimated funding for this program is approximately $4.64 million, with an expected 13 awards to be made, each with a funding limit of $200,000 for single principal investigators and $300,000 for partnering teams, over a performance period of up to two years. Interested applicants must submit a Letter of Intent by November 6, 2024, followed by a full application by November 20, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.
    Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)" aimed at promoting research on Autism Spectrum Disorders (ASD). This initiative encourages applications that investigate various aspects of ASD, including its etiology, epidemiology, diagnosis, and service delivery methods, through small, well-defined projects that can be completed within two years. The R03 grant program is particularly significant as it addresses a critical public health issue affecting many individuals and families, allowing for both clinical and non-clinical trials without the requirement for preliminary data in pilot studies. Interested applicants can apply for grants of up to $50,000, with the application deadline set for November 16, 2024. For further details, applicants may contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the funding announcement page at http://grants.nih.gov/grants/guide/pa-files/PA-21-199.html.
    Autism Research Consortium
    Active
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a grant opportunity titled "Autism Research Consortium," aimed at establishing a consortium of research institutions to enhance the evidence base for effective interventions and services for children and adolescents with autism and other developmental disabilities. Eligible applicants include public and private entities, such as research centers, faith-based organizations, and tribal entities, with no cost-sharing or matching requirements. This initiative is critical for advancing health services and support systems for affected populations, with an estimated total program funding of $4.8 million and an award ceiling of $960,000 for up to five awards. Interested parties can reach out to Deborah Quint Shelef and Emmie Perchak at AutismRC@hrsa.gov or by phone at (240) 460-5221, with proposals expected to be submitted by March 10, 2025, and project start dates anticipated for September 1, 2025.
    Autism Secondary Data Analysis Research (Autism SDAR)
    Active
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a grant opportunity titled "Autism Secondary Data Analysis Research (Autism SDAR)" aimed at supporting applied research to enhance health outcomes for children and adolescents with Autism and other Developmental Disabilities (DD). The initiative seeks to analyze existing databases and administrative records to improve the quality, efficiency, and accessibility of healthcare services for this population. This funding is critical for advancing research in the health sector, particularly in understanding and addressing the needs of individuals with Autism and DD. The estimated total program funding is $480,000, with approximately eight awards expected. Interested applicants can reach out to Sibil Varghese at AutismSDAR@hrsa.gov or by phone at (224) 448-9950. The synopsis is anticipated to be posted on October 8, 2024, with applications due by January 6, 2025, and project start dates projected for July 1, 2025.
    Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for research on Autism Spectrum Disorders (ASD) under the title "Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)." This initiative aims to support research that elucidates the etiology, epidemiology, diagnosis, and optimal service delivery methods related to ASD, encouraging applications from a diverse range of eligible organizations, including higher education institutions, non-profits, and tribal governments. The research projects may include clinical trials exploring biological or behavioral processes associated with ASD, with a focus on areas such as epidemiological studies, screening methods, and services research to enhance care for individuals with ASD. Applications are due by January 25, 2025, and interested parties can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries or assistance.